2025
DOI: 10.1016/j.vaccine.2024.126511
|View full text |Cite
|
Sign up to set email alerts
|

Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico

Constantino López-Macías,
Martha Torres,
Brenda Armenta-Copca
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 14 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?